Dr. Carolyn Lamb, MD

Dr. Lamb practices at Mount Auburn Hospital in Cambridge, Massachusetts, part of Beth Israel Lahey Health.

Dr. Lamb's NPI, 1033184783, was assigned on February 17, 2006. Dr. Lamb graduated from Feinberg School of Medicine in 1985. Dr. Lamb's Massachusetts license number on file is 72759.

Dr. Lamb's primary practice is Mount Auburn Hospital, at 330 Mount Auburn Street, Cambridge, MA 02138 in Middlesex County. The practice phone is (617) 492-3500.

Dr. Lamb's primary practice is Mount Auburn Hospital in Cambridge, Massachusetts, part of Beth Israel Lahey Health. Dr. Lamb is also affiliated with CHA Cambridge Hospital. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Lamb to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lamb practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Lamb's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lamb is board certified in radiation oncology by the American Board of Radiology. Dr. Lamb has a license on file in Massachusetts.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Lamb treats.

CMS data shows 1,423 Medicare services from Dr. Lamb across 15 procedure codes in 2024, for 177 Medicare patients. Medicare paid $88,044 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 177 Medicare patients who saw Dr. Lamb in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have cancer, and 64% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lamb's median patient age at 72, with 77% women.

In 2024, Dr. Lamb wrote 46 Medicare Part D claims for 28 patients. 96% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $212 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

Dr. Lamb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Lamb in 2011. The most frequent topics are Breast Neoplasms. Dr. Lamb's most frequent co-authors are Peter Fleck Clardy, MD, Elizabeth M. Gaughan, MD and Christina Isabella Herold, MD.

CMS Open Payments shows 53 general payments to Dr. Lamb from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Eisai Inc. paid the most, $168.

Dmand AI lists 1 award for Dr. Lamb.

Dr. Lamb graduated from Feinberg School of Medicine in 1985.

Dr. Lamb is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.